Urist Marshall

EVP, Research &Investments | EVP &Co-head Of R&I | EVP &Co-head Research &Inv.

1 company

Strong

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

-4.5%

Avg 12M Return

+13.8%

Urist Marshall is an EVP, Research &Investments at Royalty Pharma plc. Recent SEC Form 4 filings include 0 buys and 13 sells.

Estimated insider holdings value: $3.0M based on current market prices.

Holdings by Company

RPRXJan 9, 2026

Current Shares60.0K

Value$3.01M

Net Activity-326,184

Bought: 0Sold: 326.2K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 9, 2026	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	20,000	$40.78	$815,634.00	-25.0%	+20.2%	-
Jan 2, 2026	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	20,000	$38.48	$769,650.00	-20.0%	+25.0%	-
Dec 26, 2025	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	20,000	$39.32	$786,380.00	-16.7%	+19.7%	-
Dec 19, 2025	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	20,000	$38.38	$767,582.00	-14.3%	+18.0%	-
Dec 16, 2025	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	20,000	$38.32	$766,420.00	-12.5%	+20.1%	-
Dec 5, 2025	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	41,576	$39.15	$1,627,814.99	-19.9%	+15.0%	-
Dec 1, 2025	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	41,575	$39.92	$1,659,488.82	-16.6%	+19.0%	-
Feb 22, 2023	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	23,333	$37.30	$870,239.23	-33.3%	-11.0%	-16.5%
Jul 26, 2022	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	23,334	$43.18	$1,007,446.48	-54.2%	-3.6%	-26.8%
Jun 24, 2022	RPRX Royalty Pharma Plc	EVP, Research &Investments	Sell	23,333	$43.19	$1,007,693.94	-50.0%	-4.5%	-27.7%